Lupin Appoints New Compliance Manager As More Deficiencies Found

Diana Amador-Toro Takes Lead As FDA Issues Observations Over Tarapur Site

Lupin has named a new head of compliance, emphasizing the importance of achieving the highest quality standards just weeks after the FDA notified the firm of observations following an inspection at its Indian facility in Tarapur.

Compliance word circled red pen
Lupin has appointed a new compliance chief • Source: Pixsooz / Alamy Stock Photo

In recent years, Lupin has seen several ups and downs as it has grappled with quality issues across its organization, particularly when it comes to ensuring that its facilities comply with US Food and Drug Administration standards.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from Generics Bulletin